Show simple item record

dc.contributor.authorGhali, William A.
dc.contributor.authorAsh, Arlene S.
dc.contributor.authorHall, Ruth E.
dc.contributor.authorMoskowitz, Mark A.
dc.date2022-08-11T08:10:42.000
dc.date.accessioned2022-08-23T17:17:05Z
dc.date.available2022-08-23T17:17:05Z
dc.date.issued1999-04-10
dc.date.submitted2010-07-01
dc.identifier.citationAnn Thorac Surg. 1999 Feb;67(2):441-5. <a href="http://dx.doi.org/10.1016/S0003-4975(98)01138-2">Link to article on publisher's site</a>
dc.identifier.issn0003-4975 (Linking)
dc.identifier.doi10.1016/S0003-4975(98)01138-2
dc.identifier.pmid10197667
dc.identifier.urihttp://hdl.handle.net/20.500.14038/47547
dc.description.abstractBACKGROUND: Little is known about regional patterns of intraaortic balloon pump (IABP) use in coronary artery bypass graft (CABG) operations. Our objectives were (1) to identify clinical variables associated with IABP use, and (2) to examine risk-adjusted rates of IABP use for 12 Massachusetts hospitals performing CABG operations. METHODS: We used hospital discharge data to identify 6944 CABG surgical cases. Logistic regression was used to identify clinical variables associated with IABP use, and the resulting multivariate model was then used to risk adjust hospital rates of IABP use. RESULTS: The IABP was used in 13.4% of the CABG surgical cases. The clinical variables independently associated with IABP use were cardiogenic shock, same admission angioplasty, prior CABG operation, cardiac arrest, congestive heart failure, recent myocardial infarction, and urgent admission status. Risk-adjusted rates of IABP use varied widely across hospitals from 7.8% to 20.8% (p < 0.0001). CONCLUSIONS: Hospital rates of IABP use vary considerably in Massachusetts. This practice variation may be related to the persistent uncertainty regarding the precise clinical indications for the IABP in this patient population.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=10197667&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/S0003-4975(98)01138-2
dc.subjectAged
dc.subjectCoronary Artery Bypass
dc.subjectCoronary Disease
dc.subjectFemale
dc.subjectHospital Mortality
dc.subjectHospitals
dc.subjectHumans
dc.subjectIntra-Aortic Balloon Pumping
dc.subjectMale
dc.subjectMassachusetts
dc.subjectOutcome and Process Assessment (Health Care)
dc.subjectPostoperative Complications
dc.subjectRisk Assessment
dc.subjectBiostatistics
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleVariation in hospital rates of intraaortic balloon pump use in coronary artery bypass operations
dc.typeJournal Article
dc.source.journaltitleThe Annals of thoracic surgery
dc.source.volume67
dc.source.issue2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qhs_pp/681
dc.identifier.contextkey1378827
html.description.abstract<p>BACKGROUND: Little is known about regional patterns of intraaortic balloon pump (IABP) use in coronary artery bypass graft (CABG) operations. Our objectives were (1) to identify clinical variables associated with IABP use, and (2) to examine risk-adjusted rates of IABP use for 12 Massachusetts hospitals performing CABG operations.</p> <p>METHODS: We used hospital discharge data to identify 6944 CABG surgical cases. Logistic regression was used to identify clinical variables associated with IABP use, and the resulting multivariate model was then used to risk adjust hospital rates of IABP use.</p> <p>RESULTS: The IABP was used in 13.4% of the CABG surgical cases. The clinical variables independently associated with IABP use were cardiogenic shock, same admission angioplasty, prior CABG operation, cardiac arrest, congestive heart failure, recent myocardial infarction, and urgent admission status. Risk-adjusted rates of IABP use varied widely across hospitals from 7.8% to 20.8% (p < 0.0001).</p> <p>CONCLUSIONS: Hospital rates of IABP use vary considerably in Massachusetts. This practice variation may be related to the persistent uncertainty regarding the precise clinical indications for the IABP in this patient population.</p>
dc.identifier.submissionpathqhs_pp/681
dc.contributor.departmentDepartment of Quantitative Health Sciences
dc.source.pages441-5


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record